Literature DB >> 3601014

Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features.

F Alvarez, J M Roda, M Pérez Romero, C Morales, M A Sarmiento, M G Blázquez.   

Abstract

A series of 21 patients with atypical and malignant meningiomas is presented. Histological criteria such as high cellularity, typical and atypical mitosis, necrosis, infiltration of the underlying brain, poor differentiation, and distant metastasis define nonbenign meningiomas. Male predominance in this nonbenign group is significant when compared to a group of 205 benign meningiomas, which were also operated on. The malignant and atypical meningiomas are compared with the benign meningiomas, and special emphasis is placed on their computed tomographic features. The presence of tumor fringes (suggesting invasion of the brain substance) and intratumoral hypodense areas were both significant signs of malignancy of atypia. Radical surgical excision is still considered the treatment of choice.

Entities:  

Mesh:

Year:  1987        PMID: 3601014     DOI: 10.1227/00006123-198705000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  24 in total

1.  The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases.

Authors:  Ruo-Fei Liang; Ying-Jie Xiu; Xiang Wang; Mao Li; Yuan Yang; Qing Mao; Yan-Hui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Immunocytochemical study of the cellular immune response in meningiomas.

Authors:  M L Rossi; F Cruz Sanchez; J T Hughes; M M Esiri; H B Coakham
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

3.  Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones.

Authors:  A Servo; M Porras; J Jääskeläinen; A Paetau; M Haltia
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence.

Authors:  K S Lee; T Hoshino; L A Rodriguez; J Bederson; R L Davis; C B Wilson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Invasive meningioma: a tumour with high proliferating and "recurrence" potential.

Authors:  T Suwa; N Kawano; H Oka; H Ito; T Kameya
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  "Benign" metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung.

Authors:  Sofia Asioli; Rebecca Senetta; Elena Maldi; Enrico D'Ambrosio; Maria Antonietta Satolli; Gianni Bussolati; Paola Cassoni
Journal:  Virchows Arch       Date:  2007-03-13       Impact factor: 4.064

7.  Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

Authors:  T Yazaki; Y Takamiya; P C Costello; T Mineta; A G Menon; S D Rabkin; R L Martuza
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Linear accelerator-based radiosurgery in the management of skull base meningiomas.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Ngan-Ming Tsang; Kuo-Chen Wei; Chen-Kan Tseng; Joseph Tung-Chien Chang; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up.

Authors:  Faruk Ildan; Tahsin Erman; A Iskender Göçer; Metin Tuna; Hüseyin Bağdatoğlu; Erdal Cetinalp; Refik Burgut
Journal:  Skull Base       Date:  2007-05

Review 10.  Atypical and malignant meningiomas: an outcome report of seventeen cases.

Authors:  C C Coke; B W Corn; M Werner-Wasik; Y Xie; W J Curran
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.